Vectormune HVT-AIV RSS Authorised This medicine is authorised for use in the European Union Avian influenza vaccine Medicine Veterinary Authorised
Vectormune HVT-AIVVectormune HVT-AIV Overview Product details Authorisation details Assessment history News on Vectormune HVT-AIV OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine Vectormune HVT-AIV Active substance turkey herpesvirus, strain rHVT/AI-H5 (cell-associated), expressing haemagglutinin gene of Avian influenza subtype H5, Live International non-proprietary name (INN) or common name Avian influenza vaccine Pharmacotherapeutic groupImmunologicals for avesLive viral vaccinesDomestic fowl Authorisation details EMA product number EMEA/V/C/006288 Assessment history Initial marketing authorisation documents CVMP summary of positive opinion for Vectormune HVT-AIVAdopted Reference Number: EMA/CVMP/28067/2025 English (EN) (129.91 KB - PDF)First published: 14/02/2025 View News on Vectormune HVT-AIV Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 7-9 October 202510/10/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-12 February 202514/02/2025 This page was last updated on 15/04/2025 Share this page